Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
93
94
95
96
97
…
Go to page
Go
126
Next
First
Prev
95 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Indus
FDA
Apr 13, 2022
Replies
0
Views
239
Apr 13, 2022
FDA
F
E
EMA business hours over Easter holiday, , 12/04/2022
EMA
Apr 13, 2022
Replies
0
Views
221
Apr 13, 2022
EMA
E
E
EMA and the EUnetHTA 21 consortium set priorities for their collaboration , , 12/04/2022
EMA
Apr 13, 2022
Replies
0
Views
264
Apr 13, 2022
EMA
E
C
I. Shay Cosmetics Inc - 552754 - 10/29/2018
Center for Drug Evaluation and Research
Apr 10, 2022
Replies
0
Views
305
Apr 10, 2022
Center for Drug Evaluation and Research
C
F
I. Shay Cosmetics Inc - 552754 - 12/29/2021
FDA
Apr 10, 2022
Replies
0
Views
278
Apr 10, 2022
FDA
F
F
E8(R1) General Considerations for Clinical Studies
FDA
Apr 10, 2022
Replies
0
Views
246
Apr 10, 2022
FDA
F
F
Anna Health, LLC - 613294 - 03/16/2021
FDA
Apr 10, 2022
Replies
0
Views
223
Apr 10, 2022
FDA
F
F
CofixRx, LLC - 626860 - 04/05/2022
FDA
Apr 10, 2022
Replies
0
Views
262
Apr 10, 2022
FDA
F
F
Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment
FDA
Apr 10, 2022
Replies
0
Views
225
Apr 10, 2022
FDA
F
E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022, PRAC, 08/04/2022
EMA
Apr 9, 2022
Replies
0
Views
295
Apr 9, 2022
EMA
E
F
US-Canada Regional ICH Consultation - 05/11/2022
FDA
Apr 8, 2022
Replies
0
Views
332
Apr 8, 2022
FDA
F
F
eCTD Important Notices
FDA
Apr 8, 2022
Replies
0
Views
275
Apr 8, 2022
FDA
F
F
OTC Monograph Reform: Overview of Draft Guidance for Formal Meetings - 03/29/2022
FDA
Apr 8, 2022
Replies
0
Views
246
Apr 8, 2022
FDA
F
E
ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines, , 06/04/2022
EMA
Apr 8, 2022
Replies
0
Views
240
Apr 8, 2022
EMA
E
F
Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA - 02/24/2022
FDA
Apr 5, 2022
Replies
0
Views
245
Apr 5, 2022
FDA
F
F
Podcast: FDA’s Quality Metrics Reporting Program and the voluntary submission of Quality Metrics Data
FDA
Apr 5, 2022
Replies
0
Views
502
Apr 5, 2022
FDA
F
F
CDER Quality Management Maturity
FDA
Apr 5, 2022
Replies
0
Views
267
Apr 5, 2022
FDA
F
F
The ABCs of Product Specific Guidances
FDA
Apr 5, 2022
Replies
0
Views
257
Apr 5, 2022
FDA
F
F
Honey Feast, Inc. - 621651 - 03/17/2022
FDA
Apr 5, 2022
Replies
0
Views
265
Apr 5, 2022
FDA
F
F
NDAL Mfg Inc. - 621656 - 03/28/2022
FDA
Apr 5, 2022
Replies
0
Views
305
Apr 5, 2022
FDA
F
Prev
1
…
Go to page
Go
93
94
95
96
97
…
Go to page
Go
126
Next
First
Prev
95 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top